Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
JAMA Surgery|September 30, 2020
Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open GastrectomiesElvira L Vos, Erin E Salo-Mullen, Laura H Tang, et al.
Annals of Surgery|June 29, 2017
Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single InstitutionSharon A Lawrence, Marc A Attiyeh, Kenneth Seier, et al.
Annals of Surgery|October 21, 2016
Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 PatientsVivian E Strong, Sepideh Gholami, Manish A Shah, et al.
Gastrointestinal Endoscopy|April 24, 2023
Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutationsMonika Laszkowska, Laura Tang, Elvira Vos, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 15, 2024
Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognosticationIsha Singh, Joanne F Chou, Marinela Capanu, et al.
Cancer Medicine|December 4, 2024
Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young- and Average-Onset Gastric CancerPatrick T Magahis, Nicole Cornet, Laura Tang, et al.
Annals of Surgery|December 16, 2021
Risk of Lymph Node Metastasis in T1b Gastric Cancer: An International Comprehensive Analysis from the Global Gastric Group (G3) AllianceElvira L Vos, Masaya Nakauchi, Mithat Gönen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric CancerElizabeth Won, Azfar Basunia, Walid K Chatila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2026
A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic CancerBrinda Alagesan, Anna M Varghese, Celina Ang, et al.
Annals of Surgery|June 6, 2014
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinomaEileen M OʼReilly, Anna Perelshteyn, William R Jarnagin, et al.
Pageof 5